Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development Platform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. QCOM
2. MU
3. FDX
4. CBRS
5. HTZ
6. USO
7. SPY
8. KBH
9. LAES
10. HON

Go back to Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development Platform
(NASDAQ: KZIA) Delayed: 14.63 --0 (-0%)
Previous Close $14.63    52 Week High $ 
Open $14.63    52 Week Low $ 
Day High $14.63    P/E N/A 
Day Low $14.63    EPS $ 
Volume 19,006